Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$578K Sell
5,404
-8
-0.1% -$880 0.07% 116
2026
Q1
$569K Sell
5,412
-44
-0.8% -$5.17K 0.07% 108
2025
Q4
$681K Buy
5,456
+47
+0.9% +$5.6K 0.09% 87
2025
Q3
$649K Sell
5,409
-73
-1% -$7.71K 0.09% 86
2025
Q2
$503K Sell
5,482
-55
-1% -$5.02K 0.07% 105
2025
Q1
$487K Sell
5,537
-32
-0.6% -$3.15K 0.07% 97
2024
Q4
$515K Buy
5,569
+34
+0.6% +$3.27K 0.08% 89
2024
Q3
$513K Buy
5,535
+99
+2% +$8.31K 0.07% 88
2024
Q2
$408K Buy
5,436
+20
+0.4% +$1.6K 0.06% 97
2024
Q1
$467K Buy
5,416
+278
+5% +$21.3K 0.08% 88
2023
Q4
$355K Buy
5,138
+1,446
+39% +$87.3K 0.06% 96
2023
Q3
$202K Buy
+3,692
New +$210K 0.05% 134
2021
Q4
Sell
-129
Closed -$6K 228
2021
Q3
$6K Buy
+129
New +$6.54K ﹤0.01% 612

Other funds holding CRH

D'Orazio & Associates's CRH Position: Q2 2026 in Review

D'Orazio & Associates reduced its CRH (CRH) stake by 0.15% in Q2 2026, selling an estimated $880 and leaving 5,404 shares worth $578K. The position accounts for 0.07% of the portfolio, ranked #116.

D'Orazio & Associates first reported a position in CRH in Q3 2021 and has held it in 13 quarters since. The position peaked at $681K in Q4 2025. 1,025 funds tracked by Wall St. Rank hold CRH as of Q2 2026.

  • D'Orazio & Associates held 5,404 shares of CRH worth $578K as of Q2 2026.
  • D'Orazio & Associates sold 8 CRH shares in Q2 2026, an estimated $880.
  • CRH made up 0.07% of D'Orazio & Associates's portfolio in Q2 2026, its #116 holding.
  • D'Orazio & Associates first reported a position in CRH in Q3 2021 and has held it in 13 quarters since.
  • D'Orazio & Associates's CRH position peaked at $681K in Q4 2025.
  • 1,025 funds tracked by Wall St. Rank held CRH as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.